Inclisiran and siRNA-Based Lipid Lowering: A New Frontier Including ANGPTL3 Inhibitors and Apo C III Inhibitors
Cardiovascular (CV) disease remains the leading cause of death worldwide. Dyslipidemia is a well-known risk factor for CV disease. The persistent rise in heart disease despite w...